Jason Ellen
Optometrist · Jenks, OKNPI 1962405928
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.8% of the total across 278 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 19.5% — the pattern of someone who eats at a lot of different presentations. Among optometrist clinicians in OK with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 278 payments — averaging $39.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biotissue Holdings Inc.$2K
- AbbVie$1K
- Alcon$1K
- Aerie Pharmaceuticals, Inc.$781
- Tarsus Pharmaceuticals, Inc.$718
- Johnson & Johnson Surgical Vision, Inc.$639
- plus $5K from 17 others
What the payments were for
- Consulting fees$5005%
- Speaking & faculty fees$260%
- Food & beverage$10,29395%
- Gifts$390%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biotissue Holdings Inc. | 17 | $2,112 |
| AbbVie(2 entities) | 53 | $1,064 |
| Alcon | 24 | $1,015 |
| Aerie Pharmaceuticals, Inc. | 11 | $781 |
| Tarsus Pharmaceuticals, Inc. | 20 | $718 |
| Johnson & Johnson Surgical Vision, Inc. | 14 | $639 |
| Rxsight Inc | 11 | $608 |
| Bausch & Lomb Americas Inc. | 17 | $502 |
| Sun Pharmaceutical Industries Inc. | 26 | $490 |
| Amgen(2 entities) | 18 | $439 |
| Sight Sciences, Inc. | 6 | $439 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 12 | $351 |
| Dompe US, Inc. | 6 | $342 |
| Glaukos Corporation | 6 | $318 |
| The Cameron-ehlen Group, Inc. | 2 | $266 |
| Novartis | 13 | $215 |
| NEW World Medical,inc. | 2 | $160 |
| Shire North American Group Inc | 7 | $139 |
| Kala Pharmaceuticals, Inc. | 6 | $111 |
| Ocular Therapeutix, Inc. | 3 | $69 |
| Carl Zeiss Meditec AG | 2 | $39 |
| Harrow Eye, LLC | 1 | $21 |
| Astellas Pharma US Inc | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Rocklatan$617
- Tecnis IOL$606
- RXSIGHT CONTACT LENS$314
- RXSIGHT INJECTOR HANDPIECE$314
- RXSIGHT INJECTOR CARTRIDGE$314
- RXSIGHT LIGHT DELIVERY DEVICE (LDD)$314
- Prokera$268
- XDEMVY$262
- enVista MX60 IOL$240
- Oxervate$237
- OMNI$230
- Photrexa Viscous and Photrexa$195
- LIGHT ADJUSTABLE LENS (LAL)$190
- OMNI(R) SURGICAL SYSTEM (US)$150
- Hydrus$146
- XEN GLAUCOMA TREATMENT SYSTEM$142
- AmnioGraft$142
- AmnioGuard$142
- Clareon$139
- Clareon PanOptix Pro$139
How this compares
$10,857 in reported general payments places this provider in the 95th percentile of 714 optometrist providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LumiganBimatoprost | 44 | $25,865 |
| XdemvyLotilaner | 11 | $20,749 |
| ProlensaBromfenac Sodium | 57 | $20,101 |
| LotemaxLoteprednol Etabonate | 57 | $18,825 |
| Prednisolone Acetate | 506 | $18,432 |
| RocklatanNetarsudil Mesylat/Latanoprost | 38 | $15,459 |
| MoxifloxacinMoxifloxacin Hcl | 518 | $14,593 |
| BesivanceBesifloxacin Hcl | 61 | $13,663 |
| Ketorolac Tromethamine | 594 | $12,980 |
| VyzultaLatanoprostene Bunod | 37 | $12,737 |
| RhopressaNetarsudil Mesylate | 11 | $7,996 |
| CombiganBrimonidine Tartrate/Timolol | 20 | $6,827 |
| SimbrinzaBrinzolamide/Brimonidine Tart | 31 | $6,095 |
| Loteprednol Etabonate | 41 | $5,866 |
| Alphagan PBrimonidine Tartrate | 18 | $4,753 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Bausch & Lomb, A Division Of Bausch Health US, LLCProlensa, Lotemax, Besivance, Loteprednol Etabonate, Lotemax Sm | $351 | $62,630230 claims |
| AbbVieLumigan, Combigan, Alphagan P | $1,064 | $37,44582 claims |
| Aerie Pharmaceuticals, Inc.Rocklatan, Rhopressa | $781 | $23,45549 claims |
| Tarsus Pharmaceuticals, Inc.Xdemvy | $718 | $20,74911 claims |
| Bausch & Lomb Americas Inc.Vyzulta | $502 | $12,73737 claims |
| AlconSimbrinza | $1,015 | $6,09531 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 714 optometrist providers in Oklahoma.
Other optometrist in Jenks
- Sophia LeungJenks$8K
- Mary SturmJenks$5K
- Brandon HadelJenks$5K
- Haley BaldridgeJenks$5K
- Selina McGeeEdmond$1.1M
- Nathan LighthizerTahlequah$1M
- Lindsey BullTulsa$218K
- Jeff MillerTahlequah$67K
- Joseph PhillipsOklahoma City$52K
- Wesley DerosierTulsa$48K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.